Prof. Francois Amalric
Scientific Advisory member
Pharmaceutical
GENCLIS
France
Biography
A chemist by training, Dr. Amalric began his career as a researcher at the CNRS. After conducting research as a Postdoctoral Fellow at CALTECH, USA, he headed a research team at CRBGC, a CNRS laboratory in Toulouse, France, in 1977. Appointed Professor of Molecular Biology at Paul Sabatier University in Toulouse in 1986, Dr. Amalric took over direction of the Laboratory of Eukaryote Molecular Biology (UPR 9006-CNRS) in 1992, a post he held until 1998. From 1996 to 1997, he also directed the Department of Biology, Health, and Medicine of the Ministry of National Education of Higher Education and Research. He served as Director of the Institute of Pharmacology and Structural Biology of Paul Sabatier University (IPBS-UMR 5089) until 2008, when he became a Professor Emeritus. Dr. Amalric initially investigated ribosome biogenesis in eukaryotic cells, followed by the control of cell proliferation in tumor cells. These interests led him to develop a new line of research on growth factors (in particular, FGF2) and to consider the different phenotypes of endothelial cells. In parallel with his teaching and research activities, Dr. Amalric served as Adviser to the Chairman of the National Cancer Institute (INCa) for Research, as Director of the Department of Cancer Biology from 2005 to 2007, and as a member of several scientific boards, including the Scientific Board of the “Cancer-Bio-Health” Competitivity Pole in Toulouse, over which he has presided since 2009.
Research Interest
Cancer bio health rsearch and improved version of drugs and therapeutics for better healing without side effects.